
Sotera Health (SHC) Stock Forecast & Price Target
Sotera Health (SHC) Analyst Ratings
Bulls say
Sotera Health is a strong player in the healthcare industry, with increasing revenue and potential for growth in the future. Despite facing litigation, the company has made investments in compliance and has achievable goals for revenue and margin growth in the next three years. With their subsidiary Nelson Labs contributing to their performance and a focus on decreasing their net leverage ratio, Sotera stands out for their high-quality services and dedication to improving healthcare safety.
Bears say
Sotera Health is a well-established company with competitive strengths in its three business segments, especially in the integration of sterilization services and Co-60 supply capabilities. However, ongoing legal issues and potential disruptions due to government actions could negatively impact the company's financial performance. As such, the negative outlook on Sotera Health's stock is based on these potential risks and uncertainties that could affect its growth and profitability in the future.
This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.
Sotera Health (SHC) Analyst Forecast & Price Prediction
Start investing in Sotera Health (SHC)
Order type
Buy in
Order amount
Est. shares
0 shares